跳轉至內容
Merck
全部照片(1)

文件

T8275

Supelco

替马西泮标准液

analytical standard

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C16H13ClN2O2
CAS號碼:
846-50-4
分子量：:
300.74
EC號碼:
212-688-1
MDL號碼:
MFCD00057904
分類程式碼代碼:
41116107
PubChem物質ID:
329826877
NACRES:
NA.24

等級

analytical standard

品質等級

200

藥物控制

USDEA Schedule IV; Home Office Schedule 3; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

forensics and toxicology
pharmaceutical (small molecule)
veterinary

格式

neat

SMILES 字串

CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13

InChI

1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3

InChI 密鑰

SEQDDYPDSLOBDC-UHFFFAOYSA-N

基因資訊

human ... GABRA1(2554) , GABRA2(2555) , GABRA3(2556) , GABRA4(2557) , GABRA5(2558) , GABRA6(2559) , GABRB1(2560) , GABRB2(2561) , GABRB3(2562) , GABRD(2563) , GABRE(2564) , GABRG1(2565) , GABRG2(2566) , GABRG3(2567) , GABRP(2568) , GABRQ(55879)

尋找類似的產品？ 前往 產品比較指南

相關類別

應用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

生化／生理作用

催眠药

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H302,H336

危險分類

Acute Tox. 4 Oral - STOT SE 3

標靶器官

Central nervous system

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

分析證明 (COA)

Lot/Batch Number
056F0687V
056F0687
056F0687

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

Slide 1 of 1

1 of 1

(±)-氯胺酮 盐酸盐 solid

Sigma-Aldrich

K2753

(±)-氯胺酮 盐酸盐

Thomas I F H Cremers et al.
The international journal of neuropsychopharmacology, 13(6), 807-811 (2010-01-06)
Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are used as a first-line treatment in depression. However, many depressed patients are also treated with benzodiazepines to alleviate increased anxiety and sleep disturbances normally associated with depression. Since benzodiazepines inhibit 5-HT neuronal firing
Gerben Stege et al.
Respiratory medicine, 104(4), 518-524 (2009-11-17)
Benzodiazepines can improve sleep quality, but are also thought to cause respiratory depression in patients with chronic obstructive pulmonary disease (COPD). The aims of this study were to assess the effects of temazepam on indices of circadian respiratory function, dyspnea
David Wang et al.
Journal of sleep research, 20(4), 526-532 (2011-06-15)
Centrally active agents have a variable impact in patients with obstructive sleep apnoea (OSA) that is unexplained. How to phenotype the individual OSA response is clinically important, as it may help to identify who will be at risk of respiratory
R H Medema et al.
Oncogene, 31(21), 2601-2613 (2011-10-04)
DNA-damaging therapies represent the most frequently used non-surgical anticancer strategies in the treatment of human tumors. These therapies can kill tumor cells, but at the same time they can be particularly damaging and mutagenic to healthy tissues. The efficacy of
Temazepam: pharmacological profile of a benzodiazepine and new trends in its clinical application.
F Fraschini et al.
Pharmacological research, 27(2), 97-113 (1993-02-01)
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務